Brussels, Belgium

Michele M Masquelier

This inventor holds 1 USPTO granted patent. Top assignee: Institut International De Pathologie Cellulaire Et Moleculaire. Active years: 1983.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michele M Masquelier: Innovator in Pharmaceutical Science

Introduction

Michele M Masquelier is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of pharmaceutical science, particularly in the development of new medicaments. Her innovative work has led to the creation of a unique pharmaceutical form that addresses specific medical needs.

Latest Patents

Michele holds a patent for "Medicaments, their preparation and compositions containing same." This invention relates to a new pharmaceutical form of a medicament, showcasing her expertise in the formulation and preparation of effective medicinal products. She has been recognized for her innovative approach to pharmaceutical development.

Career Highlights

Michele M Masquelier has had a distinguished career, marked by her dedication to research and innovation in the pharmaceutical industry. Her work at the Institut International De Pathologie Cellulaire Et Moleculaire has been instrumental in advancing medical science. She has demonstrated a commitment to improving healthcare through her inventions.

Collaborations

Throughout her career, Michele has collaborated with notable colleagues, including Andre B Trouet and Roger M Baurain. These partnerships have enriched her research and contributed to the success of her innovative projects.

Conclusion

Michele M Masquelier is a trailblazer in the pharmaceutical field, with a focus on developing new medicaments that enhance patient care. Her contributions and collaborations reflect her commitment to advancing medical science and improving health outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…